我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

高血压左心室肥厚药物治疗进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2007年第3期
页码:
345-346/350
栏目:
综述
出版日期:
2007-06-01

文章信息/Info

Title:
-
作者:
张伟光 综述李树青 审校
辽宁医学院附属第一医院心内科, 辽宁 锦州 121000
Author(s):
-
关键词:
高血压左心室肥厚降压治疗
Keywords:
-
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
高血压患者的左心室肥厚(LVH)伴随着许多心血管事件增多的危险。有效地抗高血压治疗能够阻止高血压LVH的发展并且能逆转LVH;其中血管紧张素受体阻断剂和血管紧张素转换酶抑制剂最为有效。一些新的药物包括醛固酮阻断剂、血管肽酶抑制剂和内皮素受体阻断剂等特异性药物可能有更好效果。
Abstract:
-

参考文献/References

[1] Braz Nogueira J.Regression of left ventricular hypertrophy in hypertensiondoes it reduce cardiovascular risk?[J] .Rev Port Cardiol,2005,24(78):1007-1013.

[2] Okin PM, Devereux RB, Jern S,et al.Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events[J] .JAMA,2004,292(19):2343-2349.

[3] Conrady AO, Rudomanov OG, Zaharov DV, et al.Prospective study of the changes in left ventricular mass and geometry patterns in hypertensive patients During 5 years of followup[J].Circ J,2005,69(11):1374-1379.

[4] Gradman AH,Schmieder RE,Lins RL,et al.Aliskiren, a novel orally effective renin inhibitor, provides dosedependent antihypertensive efficacy and placebolike tolerability in hypertensive patients[J]. Circulation,2005,111(8):1012-1018.

[5] Pilz B, Shagdarsuren E, Wellner M,et al.Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in doubletransgenic rats[J]. Hypertension,2005,46(3): 569-576.

[6] Takahashi M,Minatoguchi S,Nishigaki K,et al.Longterm and strict blood pressure lowering by lmidapril reverses left ventricular hypertrophy in patients with essential hypertension: an evaluation osing a novel indicator of burden on the left ventricle[J].Hypertens Res,2006,29(2):89-94.

[7] Lonn E ,Shaikholeslami R , Yi Q,et al.Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: A substudy of the Heart Outcomes Prevention Evaluation (HOPE) trial[J].J Am coll cardiol,2004,43(12):2200-2206.

[8]Mattioli AV, Bonatti S, Monopoli D,et al.Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension[J]. Blood Press. 2005,14(5):273-278.

[9]于海波,韩雅玲,高柏青,等.替米沙坦改善原发性高血压病患者心肌肥厚及早期肾功能失调[J].心脏杂志,2005,17(1):39-41.

[10]Pitt B, Reichek N, Willenbrock R, et al.Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4Eleft ventric ular hypertrophy study[J]. Circulation,2003 ,108(15):1831-1838.

[11]Liew D,Krum H.Aldosterone receptor antagonists for hypertension: what do they offer?[J].Drugs,2003,63(19):1963-1972.

[12]张津津,姚冬芳,夏云峰.内皮素与继发性高血压的关系[J].心脏杂志,2006,18(2):234-236.

备注/Memo

备注/Memo:
收稿日期:2006-09-06.作者简介:张伟光,硕士生Email:tibird@21cn.com
更新日期/Last Update: